Clinical Trial Update: Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update examining how dolutegravir behaves pharmacokinetically in HIV-infected children coinfected with tuberculosis who are receiving s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Dolutegravir (dolutegravir)
• Rifampicin

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Pediatric HIV Infection, Tuberculosis Infection | Phase 1 | Status: RECRUITING